Triad Rx, Inc., Daphne, AL
Is Triad Rx, Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Triad Rx, Inc. hold a Alabama pharmacy license?
State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search. The Texas State Board of Pharmacy also lists nonresident license 35934 for TRIAD RX, DAPHNE, AL, status Active, as of Nov 15, 2026. The California State Board of Pharmacy also lists nonresident license NRP 3112 for Triad Rx, Daphne, AL, status Active, as of Nov 6, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054017922 for TRIAD RX INC, DAPHNE, AL, status CHANGE OF OWNERSHIP, license 054022073 for TRIAD RX INC, DAPHNE, AL, status NOT RENEWED and license 054022975 for TRIAD RX INC, DAPHNE, AL, status NOT RENEWED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002354 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0013280 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Active, license A9-0012903 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Expired and license A9-0013097 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Closed, as of Nov 10, 2026.
Has Triad Rx, Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Feb 5, 2019), 1 warning letter close-out (May 3, 2023), 1 state referral letter (May 3, 2023) and 1 FMD-145 letter (May 3, 2023) for Triad Rx, Inc. State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Triad Rx, Inc.
- Location
- Daphne, AL
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- May 3, 2023
- FDA Data Dashboard inspections
- 2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
- Form 483 text on this page
- 2 Form 483s, 10 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Triad Rx, Inc., a 503A facility, with 5 dated actions.
| Document | |||
|---|---|---|---|
| May 3, 2023 | State referral letter | State Referral Letter Issued 5/3/2023 | FDA copy (archived) |
| May 3, 2023 | Warning letter close-out | Warning Letter Close Out Issued 05/03/2023 | FDA copy (archived) |
| May 3, 2023 | FMD-145 letter | FMD-145 Letter Issued 05/03/2023 | Not linked by FDA |
| Dec 8, 2022 | Form 483 | 483 Issued 12/08/2022 | FDA copy (archived) |
| Feb 5, 2019 | Warning letter | Warning Letter (02/05/2019) | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Triad Rx, Inc, Daphne, AL (FEI number 3013497126), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Dec 8, 2022 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary): Voluntary Action Indicated (VAI) | 3013497126 | 1192322 |
| Jul 21, 2017 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3013497126 | 1018905 |
Form 483s FDA has published for this site
- Dec 8, 2022: Form 483 to Triad Rx, Inc, published Jan 11, 2023. fda.gov
- Sep 19, 2017: Form 483 to Triad Rx, Inc, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483s for this site have 10 numbered observations in all, across 2 inspections ending Jul 21, 2017 to Dec 8, 2022. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Dec 5, 2022 to Dec 8, 2022: 1 observation
- Firm on the cover
- Triad Rx, Inc, 26258 Pollard Rd, Daphne, AL 36526-4250
- FEI number
- 3013497126
- Establishment type on the cover
- Non-Sterile Drug Producer
- FDA district office on the cover
- 60 Eighth Street NE Atlanta, GA 30309
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
You produced hazardous drugs without providing adequate cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.
Specifically, there is no deactivating agent used to clean work surfaces, utensils and <Redacted B4> in between production of different hazardous drug products. Hazardous drug products produced include but are not limited to, BI-EST 50:50 (Estriol/Estradiol) in Moisturizing Lotion 5% (50mg/ml) Cream, BI-EST 50:50 (Estriol/ Estradiol)/Pregnenolone 1.5mg/60mg per ml Cream, and BI-EST 50:50 (Estriol/Estradiol)/Progest/Testo/7-K-DHEA/Pregnen 0.25mg/35mg/0. 75mg/10mg/3mg per 0.5ml Cream.
Inspection Jul 17, 2017 to Jul 21, 2017: 9 observations
- Firm on the cover
- Triad Rx, Inc., 26258 Pollard Road, Daphne, Al 36526
- FEI number
- 3013497126
- Establishment type on the cover
- Producer of Sterile and Non-sterile Drugs
- FDA district office on the cover
- 404 BNA Dr., Bldg. 200, Ste. 500 Nashville, TN 37217-2597
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Cleaning pads or wipes used in the ISO 5 area are not sterile.
Specifically, the <Redacted B4> wipers used to clean the ISO 5 area are not sterile.
Observation 2
The ISO-classified areas have difficult to clean, particle-generating, or visibly dirty equipment or surfaces.
Specifically, a lyophilizer and a portable dehumidifier are located in the clean room (ISO 7) adjacent to the ISO 5 area.
Observation 3
Inadequately or un-protected product intended to be sterile was observed to be exposed to lower than ISO 5 quality air.
Specifically, drug products intended to be lyophilized are <Redacted B4> in the ISO 5 area, partially stoppered, and then transferred to the lyophilizer (ISO 7 area) via unprotected/uncovered trays.
Observation 4
Personnel were observed touching equipment or other surfaces located outside ofthe ISO 5 area with gloved hands and then proceeding with aseptic processing without changing or sanitizing gloves.
Specifically, on 07/17/2017, I observed clean room operator, with initials <Redacted B6> perform aseptic processing in the ISO 5 area. The operator did not always disinfect or change gloves before reentering the ISO 5 area after retrieving materials or discarding waste in the ISO 7 area. The following lots were produced without adequate glove disinfection/changes:
- Sermorelin Acetate 9mg/GHRP-2 9mg Lyophililzed, lot 07172017@25
SEE '™"-OYU(lll NAMI: AND Tm.E (1'tW ot Type}
- Sermorelin Acetate 3mg/GHRP-6-3mg, Lyophilized, lot 07172017@24
Observation 5
Personnel engaged in aseptic processing were observed with exposed hands, wrists, legs, hair, or mouth.
Specifically, on 07/117/2017, I observed clean room operator, with initials <Redacted B6> enter the ISO 5 area with bare hands then put on sterile gloves and proceed with aseptic processing. The following lots were produced:
Sermorelin Acetate 9mg/GHRP-2 9mg Lyophilized, lot 07172017@25
Sermorelin Acetate 3mg/GHRP-6 3mg, Lyophilized, lot 07172017@24
Observation 6
Equipment, materials, and/or supplies are not disinfected prior to entering the aseptic processing areas.
Specifically, on 07/1712017, I observed clean room operator, with initials <Redacted B6> move a <Redacted B4> from the ISO 7 area to the ISO 5 area without first disinfecting the equipment.
Observation 7
Personnel were observed conducting aseptic manipulations or placing equipment/supplies in an area that blocked the movement of first pass air around an open unit, whether before or after it is filled with sterile product.
Specifically, on 07/117/2017, I observed clean room operator, with initials <Redacted B6> place hands and arms over open glass vials during aseptic filling of the following products:
Sermorelin Acetate 9mg/GHRP-2 9mg Lyophilized, lot 07172017@25
Sermorelin Acetate 3mg/GHRP-6 3mg, Lyophilized, lot 07172017@24
Observation 8
Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.
Specifically, your firm uses a prepared bleach water solution that consists of <Redacted B4> mixed with <Redacted B4> . However, your firm has not established an effective contact time for this concentration/strength and the contact time is not currently monitored by your firm.
Observation 9
The use of sporicidal agents in the cleanrooms and/or ISO 5 area is inadequate or infrequent.
State board of pharmacy records
State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).
| License | Type as the board gives it | Name on the board record | Location | Status | Prior disciplinary orders (file flag) |
|---|---|---|---|---|---|
| 35934 | Non-Resident (Not Located in Texas) | TRIAD RX | DAPHNE, AL | Active | No |
California State Board of Pharmacy, file dated Nov 6, 2026 (California).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| NRP 3112 | Non Resident Pharmacy | Triad Rx | Daphne, AL | Active |
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054017922 | LICENSED PHARMACY | TRIAD RX INC | DAPHNE, AL | CHANGE OF OWNERSHIP |
| 054022073 | LICENSED PHARMACY | TRIAD RX INC | DAPHNE, AL | NOT RENEWED |
| 054022975 | LICENSED PHARMACY | TRIAD RX INC | DAPHNE, AL | NOT RENEWED |
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0002354 | NONRESIDENT PHARMACY | TRIAD RX BUYER LLC (dba TRIAD RX) | DAPHNE, AL | ACTIVE (CURRENT) |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0013280 | Non Resident Pharmacy | TRIAD RX BUYER LLC (dba TRIAD RX) | DAPHNE, AL | Active |
| A9-0012903 | Non Resident Pharmacy | TRIAD RX BUYER LLC (dba TRIAD RX) | DAPHNE, AL | Expired |
| A9-0013097 | Non Resident Pharmacy | TRIAD RX BUYER LLC (dba TRIAD RX) | DAPHNE, AL | Closed |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Texas State Board of Pharmacy license file
- California State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- Texas State Board of Pharmacy disciplinary records
- California State Board of Pharmacy disciplinary records
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.